Tarsons Products share price today

Tarsons Products Ltd's share price was ₹311.10 at the close on 4 November 2026. It has been rising for 15 weeks. That is 8.4% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹177 and ₹360, and at that close it sat 73% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Tarsons Products Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 1 week running.

Over the last 4.9 years the share price moved −62% while the NIFTY 500 moved +48%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: revenue up on a year earlier for 7 quarters in a row (every quarter we can compare), profit down on a year earlier for 7 quarters in a row (every quarter we can compare) and lowest operating margin in 8 quarters.

1. Revenue up on a year earlier for 7 quarters in a row (every quarter we can compare)

   In the June 2026 quarter revenue was ₹110 crore, +20.7% on a year earlier.

   Why: US orders that had been paused by tariffs started coming back, and some turned into large orders.

   Next results: check whether US inquiries keep turning into orders and can withstand more tariff or trade trouble.

   From the earnings call on 30 Sep 2026.

2. Profit down on a year earlier for 7 quarters in a row (every quarter we can compare)

   In the June 2026 quarter profit was ₹-1 crore, -180.9% on a year earlier.

   Why: Profit fell because raw material costs rose and the company could not fully pass them on to domestic customers.

   Next results: check whether gross margin, the profit left after raw material costs, gets back to the 65% to 67% range management mentioned.

   From the earnings call on 30 Sep 2026.

3. Lowest operating margin in 8 quarters

   Operating margin was 23.6% in the June 2026 quarter, against 27% a year earlier.

   Why: The company kept less profit from each sale because it absorbed a big rise in raw material costs, passed only part of it to domestic customers, and left export prices unchanged.

   From the earnings call on 30 Sep 2026.

For April to June 2026 (the quarter ended 30 June 2026), Tarsons Products reported revenue of ₹110 crore, up 20.7% from ₹91.4 crore a year earlier, and a loss of ₹1.44 crore, down 180.9% from ₹1.78 crore.

Tarsons Products results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Tarsons Products' management discussed these results on a call held on 30 September 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Tarsons Products closed at ₹311.10 on 4 November 2026, up 15.2% from ₹269.95 a year earlier (7 November 2025) and down 62.0% over five years. Its highest weekly close since November 2021 was ₹871.10 on 16 September 2022.

Tarsons Products share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

263 weekly closes from 26 November 2021 to 4 November 2026.

4 Nov 2026: Tarsons Products closed at ₹311.10, up 6.9% on the week and down 5.6% on the month. 30 Sep 2026: Tarsons Products held its results call for April to June 2026. Management guided: Q2 gross margin 65%-67%, with full recovery not yet achieved.

Earlier

• Results for April to June 2026: Revenue up 20.7% and profit down 180.9% on a year earlier.

Tarsons Products paid no dividend in the 12 months to 5 November 2026. The last was a dividend of ₹2 a share, ex-date 20 September 2024.

Tarsons Products dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Not in its latest year. Tarsons Products Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 1 of its last 5 reported years, so there is a history but no current dividend.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 30 September 2026, Tarsons Products' management guided: Q2 gross margin 65%-67%, with full recovery not yet achieved.

“If a 100% tariff becomes a reality, I am sorry to say that there will be no trade between India and the US, not only for our business but for other businesses as well.”Santosh Agarwal, CFO, on the call for April to June 2026

What management guided

• New facilities to reach full utilization in 3-5 years and generate additional revenue of ₹400-450 crore.
• New-capital spending gross margin 65%-70%; company operating margin 35%-37% if utilization reaches 65%-70% and growth stays 15%-20%, barring disruption or price decline.
• ROCE and ROE 17%-18% after full utilization, potentially after 3-4 years.
• Debt repayment of ₹60-70 crore annually; all debt repaid within 3-4 years if 15% annual growth continues.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 30 September 2026.

When Tarsons Products reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Q2 gross-margin range and raw-material pass-through - check whether partial recovery progresses.

Tarsons Products is not on any of our India lists this week.

Tarsons Products Ltd posted a net loss of ₹1.4 Cr in the Jun 2026 quarter. Full-year FY26 profit was ₹14.0 Cr. Over 5 years profit has grown −27.3% a year on average. That loss is 1.3% of the quarter's revenue. The same quarter a year earlier earned ₹1.8 Cr. 1 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

Jun 2026 profit was −₹1.4 Cr, −180.9% on a year earlier. For the full year, FY26 profit was ₹14.0 Cr (−53.3% on the year before).

Why profit moved: revenue changed +20.7% on a year earlier and the margin moved −3.5 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed −78.0% and revenue +11.0%. Profit is growing slower than sales: rising costs are taking part of the growth.

Tarsons Products Ltd reported ₹110 Cr of revenue in the Jun 2026 quarter, +20.7% on the same quarter a year earlier. That is the 7th quarter in a row with growth on the year before. Over 5 years it has grown 13.1% a year on average. The last full year, FY26, came in at ₹423 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹441 Cr.

FY26 revenue was ₹423 Cr, +7.9% on the year before.

Recent pace: the last four quarters grew +11.0% on average, against 13.1% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +10.6%, against +14.4% a year over the last 8 quarters (rolling over); profit over the last 12 months grew −59.7%, against −54.5% a year (rolling over).

Tarsons Products Ltd's operating margin was 23.6% in the Jun 2026 quarter, 3.5 percentage points lower than the same quarter a year ago. Across 5 years it has been between 28.0% and 51.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −3.5 percentage points on the year while gross margin changed −3.0 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 385% of Tarsons Products Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹118 Cr of operating cash against ₹14.0 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹220 Cr of spending on assets, free cash was −₹102 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 385% of profit came in as cash: the cash cycle got 44 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: the bigger use of cash is spending on new assets, at 3.0× depreciation over three years. The next section checks what that spending is building.

Tarsons Products Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 361 days in FY26, up from 317 days in FY21. It spent ₹549 Cr on assets over the last 3 years. Customers take 74 days to pay, and stock sits for 341 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹423 Cr, each day of that cycle ties up about ₹1.2 Cr, so roughly ₹418 Cr is tied up in the business at any time.

FY26: customers took 74 days to pay and stock sat for 341 days, about 11.2 months of sales sitting as stock, for a full cycle of 361 days, longer than FY21's 317.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 341 days. Customers pay about 74 days after that. Suppliers are paid at 53 days. Together that makes the 361-day cycle.

Spending on assets: ₹549 Cr over the last 3 years, against ₹181 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹159 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Tarsons Products Ltd's P/E is 140.1×, near the high end of its own history: higher than 97% of past readings. Its usual P/E (the middle reading) is 49.0×, over 4.9 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹2.09.

Why the multiple is where it is: over the past year earnings per share moved −52.0% while the price moved +15.2%. The price did better than earnings, which pushed the multiple up within its own range.

Where the price move came from: over 5 years the price moved −17.6% a year; about −29.7% a year came from earnings growth and about +12.1 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Tarsons Products Ltd's business is getting worse. Profit and EPS growth are shrinking: profit growth is −59.7% in the latest quarter, against −32.0% at its best in 12 quarters, with ROCE steady at 4.5%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Tarsons Products Ltd earned a ROCE of 5% in FY26. Its return on capital used (ROIC) is 11.0 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 3.3% net margin and 0.36× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 3.3% net margin × 0.36× asset turnover × 1.87× leverage (assets divided by equity) ≈ 2.2% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 1.0% − 12.0% = −11.0 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

Tarsons Products Ltd has total debt of ₹393 Cr against shareholder equity of ₹635 Cr as of Jun 2026, so its debt is 0.62× its equity. Year by year, that ratio went from 0.04 in FY22 to 0.62 in FY26. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

Foreign institutions cut their stake in Tarsons Products Ltd by 7.5 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 0.6% of the company. Domestic institutions moved +0.4 points over the same period, to 0.6%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Foreign institutions: −7.5 points over 8 quarters, to 0.6%; Domestic institutions: +0.4 points over 8 quarters, to 0.6%; Promoters: +0.0 points over 8 quarters, to 47.3%.

Why the owners changed: foreign institutions drove it (−7.5 points). They reduced their stake.

For Tarsons Products Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

29.1 out of 100, rank 4 of 6 in Medical Equipment, with 75% of the evidence available.

Tarsons Products Ltd scores 29.1 out of 100 against the 6 companies it is compared with in Medical Equipment, ranking 4. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 5.8 + 6.2 + 5.4 + 11.7 = 29.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Tarsons Products ranks 4 of 6 Medical Equipment companies on the 4-Factor Sector Score, with 29.1 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Jun 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Medical Equipment, all 6 compared on one page.

Tarsons Products is the 2nd largest of 6 Medical Equipment companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Poly Medicure. Just below it: Laxmi Dental, Hemant Surgical Industries, Vasa Denticity and Prevest Denpro.

Medical Equipment companies close in size

1. Poly Medicure Ltd ₹14,692 crore
2. Tarsons Products Ltd ₹1,548 crore
3. Laxmi Dental Ltd ₹977 crore
4. Hemant Surgical Industries Ltd ₹916 crore
5. Vasa Denticity Ltd ₹754 crore
6. Prevest Denpro Ltd ₹510 crore

All 6 Medical Equipment companies, largest first

Companies close in size in other industries

1361. Hinduja Global Solutions Ltd ₹1,552 crore · IT Enabled Services
1362. Studds Accessories Ltd ₹1,551 crore · Plastics - Others
1363. Tarsons Products Ltd ₹1,548 crore
1364. Servotech Renewable Power System Ltd ₹1,546 crore · Capital Goods - Electric General
1365. NELCO Ltd ₹1,543 crore · Telecom Services

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.